BeOne Medicines AG
HKEX:6160
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BeOne Medicines AG
HKEX:6160
|
CH |
|
Derwent London PLC
LSE:DLN
|
UK |
|
Tompkins Financial Corp
F:8J0
|
US |
|
A
|
Agricultural Bank of China Ltd
XMUN:EK7
|
CN |
|
Telecom Italia SpA
MIL:TIT
|
IT |
|
Immobiliere Dassault SA
PAR:IMDA
|
FR |
|
P
|
Papyrus Australia Ltd
ASX:PPY
|
AU |
|
G
|
Gartner Inc
XMUN:GGRA
|
US |
|
P
|
Protec Co Ltd
KOSDAQ:053610
|
KR |
|
C
|
Chevron Corp
XMUN:CHV
|
US |
|
A
|
Accsys Technologies PLC
LSE:AXS
|
UK |
|
E
|
Ensurge Micropower ASA
OSE:ENSU
|
NO |
|
A
|
Alibaba Group Holding Ltd
OTC:BABAF
|
HK |
|
Sinclairs Hotels Ltd
BSE:523023
|
IN |
|
Tomoe Corp
TSE:1921
|
JP |
Intrinsic Value
The intrinsic value for
BeOne Medicines AG (6160) under the Base Case is hidden
HKD.
Compared with the current market price of 211 HKD, the stock appears hidden
.
Do our valuations actually work? See backtest results .
6160 looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with 6160’s past valuations and how the stock performed after similar periods.
The intrinsic value for
BeOne Medicines AG (6160) under the Base Case is hidden HKD.
Compared with the current market price of 211 HKD, the stock appears hidden.